Comprehensive Tobacco Cessation for Cancer Patients and Survivors
{ "Tobacco Cessation for Cancer Patients and Survivors", "This study is looking at the best ways to help cancer patients and survivors quit using tobacco. It offers behavioral counseling, which can be in group or individual sessions. You can join if you are 18 or older, have a history of cancer, and currently use tobacco or recently quit. The study wants to see how easy it is to offer this support and how satisfied people are with it. The goal is to improve how tobacco cessation treatment is given in cancer centers. This study aims to enroll 75 participants, but its current recruitment status is unclear.", "design": "This is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 75 participants.", "commitments": "You would attend either 6 weekly group sessions (60-90 minutes each) or up to 12 individual sessions (30-45 minutes each).", "compensation": "Not stated in the trial record.", "follow_up": "Participant satisfaction will be measured at Week 6. Other follow-up times are not specified.", }
- Study design
- Not specified.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Comprehensive Tobacco Cessation for Cancer Patients and Survivors
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Livingstone Aduse-Poku, PhD · PRINCIPAL_INVESTIGATOR · Virginia Commonwealth University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Feasibility: Consent rateAt enrollment visit
The number of individuals who consented to participate compared to the number of individuals approached for study participation.
- Feasibility: Barriers to participationAt recruitment visit
Reasons for refusal will be collected for eligible individuals who do not enroll in the study.
- Acceptability: Participant satisfactionWeek 6
Participant satisfaction ratings will be evaluated utilizing a questionnaire assessing participant satisfaction with the behavioral intervention (if applicable) and/or VCUHS pharmacotherapy management (if applicable) will be administered at each follow-up timepoint.
- Acceptability: Participant satisfactionWeek 12
Participant satisfaction ratings will be evaluated utilizing a questionnaire assessing participant satisfaction with the behavioral intervention (if applicable) and/or VCUHS pharmacotherapy management (if applicable) will be administered at each follow-up timepoint.
- Acceptability: Participant satisfactionWeek 24
Participant satisfaction ratings will be evaluated utilizing a questionnaire assessing participant satisfaction with the behavioral intervention (if applicable) and/or VCUHS pharmacotherapy management (if applicable) will be administered at each follow-up timepoint.
- Acceptability: Behavioral counseling attendance12 weeks
Participant attendance at scheduled group or 1:1 behavioral intervention sessions
- Acceptability: Nicotine replacement therapy adherenceWeek 6
Self-reported adherence to nicotine replacement therapy and/or varenicline or bupropion will be assessed at each follow-up timepoint. In addition, data re: tobacco cessation medication visits will be extracted from participants' EMR (e.g., number of visits, prescriptions written).
- Acceptability: Nicotine replacement therapy adherenceWeek 12
Self-reported adherence to nicotine replacement therapy and/or varenicline or bupropion will be assessed at each follow-up timepoint. In addition, data re: tobacco cessation medication visits will be extracted from participants' EMR (e.g., number of visits, prescriptions written).
- Acceptability: Nicotine replacement therapy adherenceWeek 24
Self-reported adherence to nicotine replacement therapy and/or varenicline or bupropion will be assessed at each follow-up timepoint. In addition, data re: tobacco cessation medication visits will be extracted from participants' EMR (e.g., number of visits, prescriptions written).